316 related articles for article (PubMed ID: 23349132)
1. Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial.
Rantalaiho VM; Kautiainen H; Korpela M; Hannonen PJ; Leirisalo-Repo M; Möttönen T;
Ann Rheum Dis; 2013 May; 72(5):786-8. PubMed ID: 23349132
[No Abstract] [Full Text] [Related]
2. [The goal for the treatment of rheumatoid arthritis should be remission].
Möttönen T; Mäkinen H; Puolakka K
Duodecim; 2010; 126(12):1457-64. PubMed ID: 20617749
[TBL] [Abstract][Full Text] [Related]
3. Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study).
Leirisalo-Repo M; Kautiainen H; Laasonen L; Korpela M; Kauppi MJ; Kaipiainen-Seppänen O; Luosujärvi R; Luukkainen R; Karjalainen A; Blåfield H; Uutela T; Ilva K; Julkunen HA; Paimela L; Puolakka K; Moilanen E; Hannonen PJ; Möttönen T;
Ann Rheum Dis; 2013 Jun; 72(6):851-7. PubMed ID: 22753402
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate.
O'Dell JR; Haire C; Erikson N; Drymalski W; Palmer W; Maloley P; Klassen LW; Wees S; Moore GF
J Rheumatol Suppl; 1996 Mar; 44():72-4. PubMed ID: 8833058
[TBL] [Abstract][Full Text] [Related]
5. Early treatment intensification induces favourable radiographic outcomes according to predicted versus observed radiographic progression in early rheumatoid arthritis: a subanalysis of the randomised FIN-RACo and NEO-RACo trials.
Levitsky A; Wick MC; Möttönen T; Leirisalo-Repo M; Laasonen L; Korpela M; van Vollenhoven RF; Rantalaiho V
Clin Exp Rheumatol; 2016; 34(6):1065-1071. PubMed ID: 27607411
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of the FIN-RACo trial; treatment with a combination of traditional disease-modifying anti-rheumatic drugs is an excellent option in early rheumatoid arthritis.
Rantalaiho V; Puolakka K; Korpela M; Hannonen P; Möttönen T
Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S27-31. PubMed ID: 23073350
[TBL] [Abstract][Full Text] [Related]
7. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.
O'Dell JR; Haire CE; Erikson N; Drymalski W; Palmer W; Eckhoff PJ; Garwood V; Maloley P; Klassen LW; Wees S; Klein H; Moore GF
N Engl J Med; 1996 May; 334(20):1287-91. PubMed ID: 8609945
[TBL] [Abstract][Full Text] [Related]
8. Remission as the treatment goal--the FIN-RACo trial.
Sokka T; Mäkinen H; Puolakka K; Möttönen T; Hannonen P
Clin Exp Rheumatol; 2006; 24(6 Suppl 43):S-74-6. PubMed ID: 17083766
[TBL] [Abstract][Full Text] [Related]
9. Treatment of rheumatoid arthritis.
Stohl W; Arkfeld DG
N Engl J Med; 1996 Sep; 335(11):821-2; author reply 822-3. PubMed ID: 8778593
[No Abstract] [Full Text] [Related]
10. Anti-citrullinated peptide antibodies and the progression of radiographic joint erosions in patients with early rheumatoid arthritis treated with FIN-RACo combination and single disease-modifying antirheumatic drug strategies.
Mustila A; Korpela M; Haapala AM; Kautiainen H; Laasonen L; Möttönen T; Leirisalo-Repo M; Ilonen J; Järvenpää S; Luukkainen R; Hannonen P
Clin Exp Rheumatol; 2011; 29(3):500-5. PubMed ID: 21640044
[TBL] [Abstract][Full Text] [Related]
11. The combination of methotrexate, sulfasalazine and hydroxychloroquine is highly effective in rheumatoid arthritis.
Furst DE
Clin Exp Rheumatol; 1999; 17(1):39-40. PubMed ID: 10084027
[No Abstract] [Full Text] [Related]
12. Combination DMARD therapy with hydroxychloroquine, sulfasalazine, and methotrexate.
O'Dell JR
Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S53-8. PubMed ID: 10589358
[TBL] [Abstract][Full Text] [Related]
13. Treatment of rheumatoid arthritis.
Zurier RB; DeMarco DM; Liu NY
N Engl J Med; 1996 Sep; 335(11):822; author reply 822-3. PubMed ID: 8778595
[No Abstract] [Full Text] [Related]
14. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.
van Vollenhoven RF; Ernestam S; Geborek P; Petersson IF; Cöster L; Waltbrand E; Zickert A; Theander J; Thörner A; Hellström H; Teleman A; Dackhammar C; Akre F; Forslind K; Ljung L; Oding R; Chatzidionysiou A; Wörnert M; Bratt J
Lancet; 2009 Aug; 374(9688):459-66. PubMed ID: 19665644
[TBL] [Abstract][Full Text] [Related]
15. Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial.
Rantalaiho V; Korpela M; Laasonen L; Kautiainen H; Järvenpää S; Hannonen P; Leirisalo-Repo M; Blåfield H; Puolakka K; Karjalainen A; Möttönen T;
Arthritis Res Ther; 2010; 12(3):R122. PubMed ID: 20576092
[TBL] [Abstract][Full Text] [Related]
16. Three out of four disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohort.
Rannio T; Asikainen J; Hannonen P; Yli-Kerttula T; Ekman P; Pirilä L; Kuusalo L; Mali M; Puurtinen-Vilkki M; Kortelainen S; Paltta J; Taimen K; Kauppi M; Laiho K; Nyrhinen S; Mäkinen H; Isomäki P; Uotila T; Aaltonen K; Kautiainen H; Sokka T
Scand J Rheumatol; 2017 Nov; 46(6):425-431. PubMed ID: 28367663
[TBL] [Abstract][Full Text] [Related]
17. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group.
Möttönen T; Hannonen P; Leirisalo-Repo M; Nissilä M; Kautiainen H; Korpela M; Laasonen L; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Ilva K; Yli-Kerttula U; Puolakka K; Järvinen P; Hakola M; Piirainen H; Ahonen J; Pälvimäki I; Forsberg S; Koota K; Friman C
Lancet; 1999 May; 353(9164):1568-73. PubMed ID: 10334255
[TBL] [Abstract][Full Text] [Related]
18. Conventional triple therapy as good as etanercept for uncontrolled rheumatoid arthritis.
BMJ; 2013 Jun; 346():f3846. PubMed ID: 23778977
[No Abstract] [Full Text] [Related]
19. The changing face of rheumatoid arthritis therapy: results of serial surveys.
Mikuls TR; O'Dell J
Arthritis Rheum; 2000 Feb; 43(2):464-5. PubMed ID: 10693890
[No Abstract] [Full Text] [Related]
20. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.
Saunders SA; Capell HA; Stirling A; Vallance R; Kincaid W; McMahon AD; Porter DR
Arthritis Rheum; 2008 May; 58(5):1310-7. PubMed ID: 18438851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
